In the original publication of this article, [Sarzynski SH, Warner S, Sun J et al. Trimethoprim-Sulfaethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals, Open Forum Infectious Diseases, Volume 9, Issue 2, February 2022, ofab644, https://doi.org/10.1093/ofid/ofab644], the column 3 header ‘Hazard Ratio’ in Supplementary Figure 2 should read ‘Adjusted Odds Ratio’ and has been updated in the version of the article currently available online.
. 2023 Apr 26;10(4):ofad198. doi: 10.1093/ofid/ofad198
Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
Collection date 2023 Apr.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
PMCID: PMC10132470 PMID: 37125232
This corrects the article "Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals" in volume 9, ofab644.